Literature DB >> 10951409

Functional implications of tissue factor localization to cell-cell contacts in myocardium.

T Luther1, D D Dittert, M Kotzsch, J Erlich, S Albrecht, N Mackman, M Müller.   

Abstract

Recently published studies suggest that the procoagulant receptor protein tissue factor (TF) is involved in vitro in cell adhesion and migration, via an interaction of its cytoplasmic domain with cytoskeletal proteins. Interestingly, TF is abundantly expressed in myocardium, but not in skeletal muscle. To elucidate the possible roles of TF in the myocardium, this study examined the cellular distribution of TF in relation to cytoskeletal proteins, as well as its relative amounts in different segments of premature, mature, and pathologically altered cardiac muscle. In juvenile and adult hearts, TF was predominantly detectable in the transverse part of the intercalated discs, where it co-localized with cytoskeletal proteins such as desmin and vinculin. The lowest amount of TF was observed in right atrial and the highest in left ventricular myocardium, which correlated with the number of contact sites of cardiomyocytes in these segments of the cardiac muscle. Lower levels of TF were present in structurally altered myocardium from patients with hypertension or ventricular hypertrophy. In addition, TF expression was decreased in human heart during sepsis and transiently decreased in rabbit heart in an endotoxaemia model, which indicates that a reduction in TF may contribute to cardiac failure in sepsis. The microtopography of TF at cardiomyocyte contact sites indicates that TF may play a structural role in the maintenance of cardiac muscle. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951409     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH667>3.0.CO;2-I

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  11 in total

1.  Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation.

Authors:  J H Erlich; E M Boyle; J Labriola; J C Kovacich; R A Santucci; C Fearns; E N Morgan; W Yun; T Luther; O Kojikawa; T R Martin; T H Pohlman; E D Verrier; N Mackman
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 2.  Role of the protein C receptor in cancer progression.

Authors:  Wolfram Ruf; Florence Schaffner
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

3.  Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms.

Authors:  Joseph S Palumbo; Kathryn E Talmage; Jessica V Massari; Christine M La Jeunesse; Matthew J Flick; Keith W Kombrinck; Zhiwei Hu; Kelley A Barney; Jay L Degen
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

4.  Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction.

Authors:  R Pawlinski; A Fernandes; B Kehrle; B Pedersen; G Parry; J Erlich; R Pyo; D Gutstein; J Zhang; F Castellino; E Melis; P Carmeliet; G Baretton; T Luther; M Taubman; E Rosen; N Mackman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

5.  Potent cardioprotection from ischemia-reperfusion injury by a two-domain fusion protein comprising annexin V and Kunitz protease inhibitor.

Authors:  C-H Yeh; T-P Chen; Y-C Wang; S-W Fang; T-C Wun
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

6.  Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.

Authors:  D N Müller; E M Mervaala; R Dechend; A Fiebeler; J K Park; F Schmidt; J Theuer; V Breu; N Mackman; T Luther; W Schneider; D Gulba; D Ganten; H Haller; F C Luft
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.

Authors:  U Boltzen; A Eisenreich; S Antoniak; A Weithaeuser; H Fechner; W Poller; H P Schultheiss; N Mackman; U Rauch
Journal:  J Mol Cell Cardiol       Date:  2012-01-31       Impact factor: 5.000

Review 8.  Tissue factor, protease activated receptors and pathologic heart remodelling.

Authors:  Silvio Antoniak; Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Thromb Haemost       Date:  2014-08-07       Impact factor: 5.249

9.  Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis.

Authors:  Suet Yen Chong; Olga Zharkova; Siti Maryam J M Yatim; Xiaoyuan Wang; Xiong Chang Lim; Chenyuan Huang; Chia Yee Tan; Jianming Jiang; Lei Ye; Michelle Siying Tan; Veronique Angeli; Henri H Versteeg; Mieke Dewerchin; Peter Carmeliet; Carolyn S P Lam; Mark Y Chan; Dominique P V de Kleijn; Jiong-Wei Wang
Journal:  Theranostics       Date:  2021-09-03       Impact factor: 11.556

10.  A new method to determine tissue specific tissue factor thrombomodulin activities: endotoxin and particulate air pollution induced disbalance.

Authors:  Kim Frederix; Ingeborg M Kooter; René van Oerle; Diane Fens; Karly Hamulyak; Miriam E Gerlofs-Nijland; Hugo Ten Cate; Henri Mh Spronk
Journal:  Thromb J       Date:  2008-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.